chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a patient family member or friend and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (has long haul Covid) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included MS and Living in residential institution. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POST-ACUTE COVID-19 SYNDROME (has long haul Covid) (seriousness criterion medically significant). The patient was treated with OXYGEN for Breathing difficult, at an unspecified dose and frequency. At the time of the report, POST-ACUTE COVID-19 SYNDROME (has long haul Covid) had not resolved. No Concomitant medications were provided. It was reported that patient had no cough after third dose. Patient was on oxygen due to breathing problems. Breathing difficult subsumed under Long Covid-19. Company Comment: This is a spontaneous case concerning a 71-year-old, male patient with medical history of multiple sclerosis living in a nursing home, who experienced the unexpected serious AESI of Post-acute COVID-19 syndrome. Patient experienced COVID-19 after the second dose of COVID-19 vaccination and developed long haul COVID-19 after the booster dose of mRNA-1273 vaccine. Patient is on oxygen due to breathing problems. Patient underlying condition is a risk factor for the requirement of supplemental oxygen. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. This case was linked to MOD-2022-642064 (Patient Link). Sender's Comments: This is a spontaneous case concerning a 71-year-old, male patient with medical history of multiple sclerosis living in a nursing home, who experienced the unexpected serious AESI of Post-acute COVID-19 syndrome. Patient experienced COVID-19 after the second dose of COVID-19 vaccination and developed long haul COVID-19 after the booster dose of mRNA-1273 vaccine. Patient is on oxygen due to breathing problems. Patient underlying condition is a risk factor for the requirement of supplemental oxygen. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
pt returned to clinic 3 days later and has a local reaction on the arm.  area slightly raised and warm and pink to the touch.
Divet in arm.25 of inch deep, 1.5inch in ircymference...light red, muscle bulged under indentation, 1.5x1.5 bulge, no pin
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 08-OCT-2012 12:35, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not provided. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
slowly devel apprx 1 day p/shot pain, sl red worse over 2 wks inc redness, ince pain, inc induration;
PATIENT RECOVERED AND WAS SENT HOME TO CONTINUE RESTING AT HOME. PATIENT FELT BETTER PRIOR TO LEAVING CLINIC. Dizziness & DIZZINESS, CHILLS, SHOULDER PAIN AT INJECTION SITE
VACCINE WAS REFROZEN; ADMINISTRATION OF REFROZEN VACCINE; This spontaneous report received from a health care professional concerned a 52 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: 20-MAR-2022) dose was not reported, administered on 08-SEP-2021 for prophylactic vaccination. Age at time of vaccination 52 years old. No concomitant medications were reported. On 08-SEP-2021, the patient experienced administration of refrozen vaccine. On an unspecified date, the patient experienced vaccine was refrozen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine was refrozen and administration of refrozen vaccine was not reported. This report was non-serious. This case, involving the same patient is linked to 20220538379. This case, from the same reporter is linked to 20220537356, 20220537532, 20220537683, 20220538238, 20220537444, 20220537548, 20220539045, 20220538425, 20220538428, 20220538297, 20220538573, 20220538480, 20220538149, 20220538437, 20220538666, 20220537341, 20220538292, 20220538411, 20220538316, 20220538210, 20220538693, 20220540435, 20220538146, 20220538758, 20220540474, 20220537507, 20220540853, 20220541180, 20220540570, 20220540688, 20220538347, 20220540642, 20220540814, 20220540765, 20220540420 and 20220540816.
Severe dizzyness, vomiting, tongue swelling,. Took ambulance to hospital. Stay at hospital 6 hours. Started at home for there days from work. Tongue and throat are still sore.
Patient was given a Pfizer covid-19 5-11 on 10/08/2022. The product has since been recalled by Pfizer for being   received short-dated and recently expired.
3 months after receiving the Pfizer Covid Vaccine I developed a severe case of Shingles. I'm a pretty active and healthy individual, and I read that some patients are developing Shigles after gettinfg the vaccine. I want my case to be included in the repoting and the studies being done, I do think my case might be related to the vaccine. I don't have major health issues and this Shingles took me by surprise
Client reported 10 days post vaccination her left arm became warm, swollen, with urticaria and redness from her deltoid vaccination site to her elbow. She saw her PCP who told her this was an allergic reaction to the vaccine; started her on oral Keflex and a Medrol dose pack.
This spontaneous report was received from a registered nurse referring that an unspecified numbers of patients may had been vaccinated on unspecified dates with PNEUMOVAX23 (lot # not reported) that was improperly stored, within the month of April. Additional information has been requested.
Invalid dose due to incorrect diluent used while drawing up the vaccine. No adverse events. patient must come back to office for repeat dose per our immunization coordinator who spoke with the state. patient was called and was made aware of the situation by primary care Dr. patient is scheduled to come back to the office on 10/03/2022 for repeat vaccine.
Burning at injection site for several hours following shot.   Slight headache 1-2 hrs after.   Body aches & chills 16 hrs after injection.  Symptoms subsided after taking advil dual action.   29 hrs after injection Symptoms returned stronger than previously.   I slept about 6 hours.   Symptoms still present but not as bad as earlier
Received flu vaccine 2/1/06. Developed localized soreness to right arm at injection site. Flu symptoms started 2/3/06 fever, achiness, chills. Illness continued through 2/9/06 then started feeling better. Awakened early am 2/12/06 with swelling and pain whole right arm. Treated initially with antibiotic and later with anti inflammatory.
fever began 19MAY98 101;20MAY98 T105 fever in AM & rash neck, side of underarm, temp went down w/APAP;T101 & 102 21MAY98;sleeplessness;no fever 22OCT98;clear runny nose 19MAY98, 20MAY98;
mom relates pt devel a knot & redness @ inject site on the day of inject; redness cont to worsen on 22JUL93; noticed areas w/pus in it; oral ATB; sterile abscess;
Information has been received regarding a case in litigation concerning a male child who was injected with vaccinations containing the toxic mercury-based preservative thimerosal during the 1st year of his life from 8/93 through 1994 and every time he received a multidose vaccine. The alleged results of these vaccinations are that the pt sustained severe and permanent personal injuries, including being dx'd with severe autism and other neurological disorders. In addition, it is alleged that the pt has sustained further neurological insult from other vaccines, including MMRII, which does not contain thimerosal, but caused further neurological insult and exacerbated the neurological disorders from the prior thimerosal exposure. Upon internal review, permanent personal injuries, severe autism, neurological disorders and the exacerbation of the neurological disorders were considered to be "Other Important Medical Events". No further information is available.
Local reaction to DTaP. Redness and swelling of left thigh measuring 6 cm by 8 cm. Onset of symptoms began 10/31/2001. Child was evaluated on 11/02/2001 for local reaction. Still has redness on 11/05/2001.
The pt received the TD in the left deltoid at approximately 11:00 PM on 3/26/00. It was noted that the pt experienced left arm pain on 3/27/00 at approximately 8:00 AM. The pt experienced a gradual increase of fatigue, epigastric pain at 8:00 PM. A fever was noted at 9:00 PM along with chest tightness, local reaction (redness and tender deltoid). Treatment existed of Allegra, ibuprofen.  Symptoms have resolved except chest tightness reoccurred on 3/28/00 at 4:00 PM and fever of 100.2.
This spontaneous report was received from a licensed practical nurse, and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On unknown dates, the patient was vaccinated with VARIVAX lot N022995, expiry 23-AUG-2019, lot N012619, expiry 21-APR-2019, for prophylaxis and PROQUAD lot N023965, expiry 28-FEB-2019, lot N015625, expiry 15-NOV-2018 for prophylaxis. (routes of administration were not reported for any of the aforementioned vaccines). The sterile diluent (MERCK) used for reconstitution was properly stored (lot number and expiry date unknown). No adverse effects were reported. On unknown dates, the doses of VARIVAX and PROQUAD underwent temperature excursions of 6 degrees Fahrenheit (°F) to 14 °F (6.1°F) for 16 minutes. Previous temperature excursions were reported as follows: 6 °F to 14 °F (9.7°F) for 30 minutes, 6 °F to 14 °F (6.3°F) for 15 minutes and 6 °F to 14 °F (6.8°F) for 8 minutes. Total cumulative: 6 °F to 14 °F for 69 minutes. This is one of several cases received from the same reporter. Sender's Comments: US-009507513-1802USA005899: US-009507513-1801USA010912: US-009507513-1802USA005898.
red and splotchy rash on feet, hands, stomach, chest appeared 9 days after moderna vaccine
Patient was seen 12/16/2020 and given 12 month vaccines. On 12/21/2020 seen in E.R for elevated temp. @ 106. Was tested for flu. RSV. Covid-19 all neg 0 results. E.R  M.D. dx was adverse reaction to vaccines
after she received the rabies vaccine she never got trigeminal neuralgia again; Initial information received on 23-Apr-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a female patient who received the RABIES (HDC) VACCINE [IMOVAX RABIES vaccine and then she never got trigeminal neuralgia again.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect RABIES (HDC) VACCINE (formulation: Powder and solvent for suspension for injection) lot number and expiry date was not reported via unknown route in unknown administration site.  On an unknown date, the patient reported that after she received the rabies vaccine she never got trigeminal neuralgia again (therapeutic response unexpected) (Unknown latency) following the administration of RABIES (HDC) VACCINE.  (Other relevant tests included No lab data.)  List of document held by sender: none.
Received  vaccine on 3.12.2021; began to have tearing of R eye with erythema on 3.24.2021 at approx 20:30; awakened 3.25.2021 with swelling of R eyelid, inability to blink, R side facial numbness, R side tongue numbness;  Diagnosis: Bell Palsy; Rx Prednisone taper, Neurontin, Valacyclovir, moisturizing eye drops, eye patch.
G1 Stomachache; G1 Fever; G2 Fatigue/lingering G1 fatigue; G1 Nausea; Fainted and fell on the ground breaking my front incisive; Fainted and fell on the ground breaking my front incisive; Fainted and fell on the ground breaking my front incisive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (COMIRNATY), on 22Apr2022 at 13:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 54 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 3 (Booster)), for Covid-19 Immunization; Covid-19 vaccine (Primary immunization series complete, manufacturer unknown), for Covid-19 Immunization. The following information was reported: DIZZINESS (non-serious), FALL (non-serious), TOOTH INJURY (non-serious) all with onset 22Apr2022, outcome "unknown" and all described as "Fainted and fell on the ground breaking my front incisive"; PYREXIA (non-serious) with onset 22Apr2022, outcome "unknown", described as "G1 Fever"; NAUSEA (non-serious) with onset 22Apr2022, outcome "unknown", described as "G1 Nausea"; FATIGUE (non-serious) with onset 22Apr2022, outcome "unknown", described as "G2 Fatigue/lingering G1 fatigue"; ABDOMINAL PAIN UPPER (non-serious) with onset 23Apr2022, outcome "unknown", described as "G1 Stomach ache".  Additional information: Within a couple of hours experienced G1 Fever, G2 Fatigue, G1 Nausea. Went to bed at 4:00pm. Woke up at 9:00pm to go pee. Fainted and fell on the ground breaking my front incisive. 23Apr2022: G1 Stomach ache and lingering G1 fatigue.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
At 4:30 the afternoon of the second dose, I had what felt like a knife stabbing in my arm at the injection site. It ran all the way down to my fingers. I then had a fever of 102, severe chills, nausea, and vomiting. I went to the ER and was given IV fluids, Valium, and nausea meds. Experienced chills and fever for about four days. I was diagnosed with Alopecia. I went to a dermatologist and received injections. Four weeks after, I had problems with my left shoulder.
Every time I get a flu shot I get the flu; Initial information received  from on 13-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp via digital media.  This case involves patient of unknown demographics who reported every time he/she get a flu shot he/she get the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation,route administration site, frequency, lot number and expiry date was unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event " every time i get a flu shot i get the flu "(influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Every time I get a flu shot I get the flu).  At time of reporting, the outcome was Unknown for the event every time i get a flu shot i get the flu.
Injection site painful. No obvious infection. No edema nor erythema. Patient to use local warm heat and TYLENOL or ADVIL for pain.
Her tongue was swollen; Arm at the injection site is lumpy; Lump in her right arm; Arm at the injection site is red; Left arm at the injection site is swollen at about 5-6inches long; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Her tongue was swollen), VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (The patient was allergic to oxycodone.). Concomitant products included ACYCLOVIR [ACICLOVIR] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced SWOLLEN TONGUE (Her tongue was swollen), VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 07-Feb-2021, SWOLLEN TONGUE (Her tongue was swollen) had resolved. At the time of the report, VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
appears he is experiencing muscle weakness; eye drooping; persistent headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of MUSCULAR WEAKNESS (appears he is experiencing muscle weakness), EYE DISORDER (eye drooping) and HEADACHE (persistent headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (appears he is experiencing muscle weakness), EYE DISORDER (eye drooping) and HEADACHE (persistent headache). At the time of the report, MUSCULAR WEAKNESS (appears he is experiencing muscle weakness), EYE DISORDER (eye drooping) and HEADACHE (persistent headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
6  days post injection developed a welt on arm, but not at int site, Large Lymph node swelling on collarbone and stiff neck. 7 -14 additional welts on injection arm. Temperature on the arm is 96 on arm with swelling and 90 on non injection arm. Taking OTC benedryl and using OTC hydrocortisone on the 2 welts on int arm
This spontaneous report was received from a Nurse referring to a 4 month old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On an unknown date, the patient was vaccinated with PROQUAD (route, dose, frequency, anatomical location, indication, lot # and expiration date were unknown) with lot # N025927, and expiration date 18-MAR-2019 for prophylaxis. No adverse effects were reported.
Dizziness, Fever, HYPERtension & Tachycardia Narrative:  Pt agreed to go to the ED for further observation for above events after 2nd dose of covid vaccine. She is AAOx3, VS wnl at this time. Sx resolved by 20" completely after bedadryl; opted to leave and return to work in stable condition.
bowel issues; cramping; stomach spasm,stomach issues; dizziness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL DISORDER (bowel issues), MUSCLE SPASMS (cramping), GASTROINTESTINAL PAIN (stomach spasm,stomach issues), DIZZINESS (dizziness) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced GASTROINTESTINAL DISORDER (bowel issues), MUSCLE SPASMS (cramping), GASTROINTESTINAL PAIN (stomach spasm,stomach issues), DIZZINESS (dizziness) and FATIGUE (fatigue). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at an unspecified dose and frequency and PROBIOTICS NOS at an unspecified dose and frequency. At the time of the report, GASTROINTESTINAL DISORDER (bowel issues), MUSCLE SPASMS (cramping), GASTROINTESTINAL PAIN (stomach spasm,stomach issues), DIZZINESS (dizziness) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information also include Bland diet.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain and influenza-like symptoms. On an unknown date, the outcome of the injection site pain and influenza-like symptoms were unknown. It was unknown if the reporter considered the injection site pain and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination were not reported. The reporter (daughter of the patient) stated that the patient experienced pain at injection site and flu like symptoms after receiving the SHINGRIX. This case has been linked with case US2018GSK077003 and US2018GSK164087 reported by the same reporter.
04jan90 pt vax hepta B on 05jan90 pt awoke w/ nausea/hives on both feet. pt ex. fatigue & sweats which lasted 4 days.  after 2 days hives resolved. 09jan90 pt presented 1cm tender L-posterior cervical node. pt recovered.
Moderna COVID-19 Vaccine EUA  First symptoms appeared about 8PM the evening of the shot - a feeling of being weighted down, with extra difficulty in moving about.  I went to bed early and when I woke up I had a fever of 101.5 accompanied by chills, body aches, nausea, fatigue, brain fog, and headache.  Over the course of two days, my temperature ranged from 101.5 to 103.  After two days my fever broke during the night.   I did not want to take fever reducing medication in case it interfered with the immune response, but I did take 1 dose each of Tylenol and Motrin over the course of the 2 days.  Still felt a bit sluggish on the 3rd day and continue to have brain fog 6 days later.
Pain and minor swelling in her arm started after the vaccine. Patient said she had experienced pain from previous vaccine and usually a cold compress will resolve the issue. The patient refused treatment.
Patient reported swelling in his legs, knee trouble (making walking difficult), dizziness, headaches, temporary memory loss and tired. These were all experienced for about 2 1/2 weeks post 2nd dose of Moderna vaccine.